Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Single-Photon Emission Computed Tomography (SPECT) Market CAGR Outlook And Future Development
The single-photon emission computed tomography (spect) market has demonstrated robust expansion recently. Its valuation is projected to increase from $2.5 billion in 2025 to $2.73 billion in 2026, registering a compound annual growth rate (CAGR) of 9.1%. Historically, this growth has been driven by factors such as the broadening of nuclear medicine applications, an increase in diagnostic imaging procedures, the rising occurrence of cardiovascular and neurological disorders, greater hospital investments in imaging infrastructure, and the uptake of radioisotope-based diagnostics.
The single-photon emission computed tomography (spect) market size is projected to experience robust expansion over the next few years. It is forecast to reach $3.92 billion in 2030, advancing at a compound annual growth rate (CAGR) of 9.5%. The market’s growth during the forecast period is attributable to factors such as increasing demand for advanced molecular imaging, rising adoption of precision diagnostics, the expansion of outpatient diagnostic centers, growing integration of AI in medical imaging, and an increasing focus on early disease detection. Significant trends anticipated in this period involve the increasing adoption of hybrid spect imaging systems, a rising use of AI-assisted image reconstruction, growing demand for cardiac and oncology imaging, the expansion of multi-head gamma camera systems, and an enhanced focus on diagnostic accuracy.
Get A Free Sample Report With In-Depth Market Insights:
Single-Photon Emission Computed Tomography (SPECT) Market Growth Factors: What’s Supporting Expansion?
An expected increase in cancer incidence is poised to drive the expansion of the single-photon emission computed tomography (SPECT) market moving forward. This escalation in cancer cases is attributed to an aging population, unhealthy lifestyle choices, and environmental factors. Single-photon emission computed tomography (SPECT) assists in the diagnosis, staging, and monitoring of cancer, often alongside other imaging techniques like computed tomography (CT) and Magnetic Resonance Imaging (MRI) scans. For instance, in 2023, as reported by Cancer Australia, an Australia-based government agency, approximately 8,257 new cases of melanoma of the skin were diagnosed, representing 2.6% of all cancer deaths. Therefore, the increasing prevalence of cancer cases is propelling the growth of the single-photon emission computed tomography (SPECT) market.
Single-Photon Emission Computed Tomography (SPECT) Market Segments: Where Is Growth Concentrated?
The single-photon emission computed tomography (spect) market covered in this report is segmented –
1) By Type: Hybrid SPECT Systems, Standalone SPECT Systems
2) By Type Of Radioisotopes: Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Other End User
Subsegments:
1) By Hybrid SPECT Systems: SPECT Or CT Systems, SPECT Or MRI Systems
2) By Standalone SPECT Systems: Single-Head SPECT Systems, Multi-Head SPECT Systems
Single-Photon Emission Computed Tomography (SPECT) Market Industry Trends: What’s Reshaping Demand?
Leading firms involved in Single-photon emission computed tomography (SPECT) are developing innovative products, such as portable gamma cameras, to enhance market revenues. Portable gamma cameras are defined as compact, mobile nuclear imaging instruments utilized to detect gamma radiation emitted from radiopharmaceuticals within the body. For example, in June 2023, Serac Imaging, a UK-based molecular imaging company, unveiled a portable high-resolution hybrid gamma optical camera. This device is engineered to complement the technology currently in use in nuclear medicine departments and aims to simplify workflows while providing additional capacity.
Single-Photon Emission Computed Tomography (SPECT) Market Key Participants And Competitive Landscape
Major companies operating in the single-photon emission computed tomography (spect) market are GE Healthcare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, United Imaging Healthcare Co. Ltd., Mediso Ltd., Spectrum Dynamics Medical Inc., Digirad Corporation, Gamma Medica Inc., Neusoft Medical Systems Co. Ltd., Trasis S.A., Curium Pharma, Lantheus Holdings Inc., Bracco Imaging S.p.A., Guerbet S.A., Eckert & Ziegler AG, Nordion Inc., Bayer AG, Advanced Accelerator Applications, Ion Beam Applications S.A., Hitachi Ltd.
View The Full Single-Photon Emission Computed Tomography (SPECT) Market Report:
Single-Photon Emission Computed Tomography (SPECT) Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the single-photon emission computed tomography (SPECT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the single-photon emission computed tomography (SPECT) market report during the forecast period. The regions covered in the single-photon emission computed tomography (spect) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
